<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The objective of the present study is to observe the effect of Astragalus <z:chebi fb="5" ids="18154">polysaccharide</z:chebi> (APS) on myocardial <z:chebi fb="105" ids="17234">glucose</z:chebi> and <z:chebi fb="23" ids="18059">lipid</z:chebi> metabolism in <z:mp ids='MP_0002055'>diabetes</z:mp> (DM) hamster and to explore its mechanism in intervention of DM <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Low-dose- <z:chebi fb="1" ids="9288">streptozotocin</z:chebi>-induced hamsters (STZ, 40 mg/kg × 3 days, i.p.) with blood <z:chebi fb="105" ids="17234">glucose</z:chebi> &gt;13.9 mmo/L were considered as type 2 diabetic models </plain></SENT>
<SENT sid="2" pm="."><plain>We measure blood <z:chebi fb="105" ids="17234">glucose</z:chebi>, serum <z:chebi fb="23" ids="18059">lipid</z:chebi>, insulin, C-<z:chebi fb="7" ids="16670">peptide</z:chebi>, myocardial enzyme levels, myocardial <z:chebi fb="15" ids="28087">glycogen</z:chebi> staining, myocardial ultrastructure, fluorescence quantitative RT-PCR detection of myocardial PPAR-α and the target genes (FATP, ACS) and GLUT4 <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression in <z:mpath ids='MPATH_458'>normal</z:mpath> control group, DM group and APS treatment group hamsters </plain></SENT>
<SENT sid="3" pm="."><plain>There was significant <z:chebi fb="0" ids="33563">glycolipid</z:chebi> <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic disorders</z:e> in DM group compared with <z:mpath ids='MPATH_458'>normal</z:mpath> group </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="105" ids="17234">Glucose</z:chebi>, glycosylated serum protein, myocardial enzymes and <z:chebi fb="23" ids="18059">lipid</z:chebi> levels in APS treatment group decreased significantly than DM group, but insulin and C-<z:chebi fb="7" ids="16670">peptide</z:chebi> levels was no difference </plain></SENT>
<SENT sid="5" pm="."><plain>Myocardial <z:chebi fb="15" ids="28087">glycogen</z:chebi> staining and abnormal myocardial ultrastructure in APS treatment group were significantly improved than in DM group </plain></SENT>
<SENT sid="6" pm="."><plain>Gene expression of myocardial PPAR-α and its target genes (FATP, ACS) in APS group were significantly lower than in DM group, while gene expression of GLUT4 in APS group was higher than DM group </plain></SENT>
<SENT sid="7" pm="."><plain>APS can partially improve myocardial <z:chebi fb="105" ids="17234">glucose</z:chebi> and <z:chebi fb="23" ids="18059">lipid</z:chebi> <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolism disorders</z:e> in diabetic hamsters and protect myocardium in some extent </plain></SENT>
</text></document>